Lanreotide

Lanreotide
Product Description

Under development - samples available

Aspen Healthcare. We Care

  • NL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Product Performance; Quality Service; Reputation
  • Supplied from
    Netherlands
  • Measured In
    gram

Aspen Healthcare. We Care

  • NL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)

More Products from Aspen Healthcare. We Care (4)

  • Segesterone acetate

    Product Segesterone acetate

    Under development - samples are available
  • Sugammadex

    Product Sugammadex

    Commercially available
  • Morphine Sulfate

    Product Morphine Sulfate

    This API is part of the FCC product portfolio and is available for selected markets only
  • Morphine Tartrate

    Product Morphine Tartrate

    This API is part of the FCC product portfolio and is available for selected markets only

Aspen Healthcare. We Care resources (3)

  • Sponsored Content Aspen API’s Green answer to peptide synthesis

    Our Green Continuous Liquid Phase Peptide Synthesis (GC-LPPS) combines the advantages of the classical solution-phase synthesis with the solid-phase approach. 
  • Brochure Aspen. Healthcare. We Care.

    Aspen is a global specialty and branded pharmaceutical company committed to promoting access to medicines and improving the health of patients across the world through our high quality, affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability.
  • News CPHI Trend Report - Sustainability in Pharma

    While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only understand that it represents one of the world’s biggest challenges moving forward, but also that they are starting to incorporate sustainability practices into a much broader suite of operations.